ARIUS Research

Contact
ariusresearch.com
+14168622323

ARIUS Research Inc.

55 York Street, 15th Floor
M5J 1R7 Toronto
Canada
+14168622323
ariusresearch.com
Contact
Profile News
Contact

About ARIUS Research

ARIUS is a biotechnology company discovering and developing the next wave of antibody therapeutics. Established in 1999, ARIUS has built a proprietary technology platform, FunctionFIRST(TM), that rapidly identifies and selects antibodies based on their functional ability to affect disease. This antibody generation engine has enabled ARIUS to assemble a portfolio of more than 400 antibody candidates. In addition to the antibodies it is developing in-house, ARIUS has ongoing partnerships with key biotechnology and drug development companies.

Read more about ARIUS Research
Facts about ARIUS Research
  • Industry : Biotechnology

News about ARIUS Research

ARIUS Research

25-Jul-2008 | business & finance

Roche starts acquisition process of ARIUS to gain access to new screening platform for antibody therapeutics

Roche and ARIUS Research Inc. announced that the two companies have signed a definitive agreement for Roche to acquire ARIUS in an all-cash transaction at ...

Read news
ARIUS Research

20-Feb-2008 | research and development

ARIUS presents new findings showing therapeutic antibody inhibits human leukemic cancer stem cells

ARIUS Research Inc. announced that new information on the preclinical activity of its anti-CD9 cancer stem cell antibody will be presented at the AACR ...

Read news
ARIUS Research

07-Dec-2007 | business & finance

ARIUS announces manufacturing agreement with Avid Bioservices for CD44 Cancer Stem Cell antibody

ARIUS Research Inc. announced that it has entered into a manufacturing supply and technology transfer agreement for its CD44 Cancer Stem Cell antibody with ...

Read news
ARIUS Research

30-Oct-2007 | research and development

Arius announces new findings in Trop-2 and CD59 CANCER antibody programs

CD59 antibody uses novel approach to "de-cloak" cancers

Read news
ARIUS Research

03-Aug-2007 | research and development

ARIUS announces allowance of US patent for lead anti-cancer antibody

ARIUS Research Inc. announced that the Company has received notice from the United States Patent and Trademark Office that a key patent for its lead anti- ...

Read news
ARIUS Research

12-Mar-2007 | research and development

US Patents Granted for ARIUS Antibodies

ARIUS Research Inc. announced that it has been granted two new United States patents for antibodies within their CD63 program. Patent 7,175,846. covers ...

Read news
ARIUS Research

30-Nov-2006 | research and development

ARIUS Receives Six Key US Patents

Strengthens Intellectual Property Portfolio on Lead Programs and Antibody Assets

Read news
ARIUS Research

06-Apr-2006 | business & finance

ARIUS Research Signs Anti-Cancer Antibody Discovery Deal with Takeda

Three-Year Collaboration to look for Novel Cancer Treatments

Read news
Show more news about ARIUS Research

Here you will find ARIUS Research Inc.